Usefulness of rheumatoid factor in comparison with another antibodies in rheumatoid arthritis;Celowość oznaczania czynnika reumatoidalnego w zestawieniu z wartościa̧ wykrywania innych przeciwciał wystȩpuja̧cych w reumatoidalnym zapaleniu stawów

Reumatologia

Volumn 41, Issue 1, 2003, Pages 55-68

  Biernacka, Elwira ^a   Za̧bek, Jakub ^a  

^a INSTITUTE OF RHEUMATOLOGY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; COLLAGEN ANTIBODY; FILAGGRIN; IMMUNOGLOBULIN M ANTIBODY; KERATIN ANTIBODY; RA 33 ANTIBODY; RHEUMATOID FACTOR; SA ANTIBODY; UNCLASSIFIED DRUG;

ANTIGEN ANTIBODY REACTION; CORRELATION ANALYSIS; DIAGNOSTIC VALUE; DISEASE CLASSIFICATION; HUMAN; MIXED CONNECTIVE TISSUE DISEASE; PROTEIN BLOOD LEVEL; RELIABILITY; REVIEW; RHEUMATOID ARTHRITIS; SERUM;

EID: 1842768549     PISSN: 00346233     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (61)

1. Aho K., Palosuo T., Raunio V. et al.: When does rheumatoid disease start? Arthritis Rheum., 1985, 28, 485.
2. Aho K., Palosuo T., Lukka M.: Antifilaggrin antibodies in recent - onset arthritis. Scand. J. Rheumatol., 1999, 28, 113.
3. Arnett F.C., Edwarthy S.M., Bloch D.A. et al.: The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum., 1988, 31, 315.
4. Bal J., Lawrence J.S.: Epidemiology of sheep cell agglutination test. Ann. Rheum. Dis., 1961, 20, 253.
5. Bampton J.L.M., Cawston T.E., Kyle M.V., Hazelman B.L.: Measurement of rheumatoid factor by enzyme-linked immunosorbent assay (ELISA) and comparison with other methods. Ann. Rheum. Dis., 1985, 44, 13.
6. Bernnett P.H., Wood P.H.N., Editors: Population Studies of the Rheumatic Diseases. Amsterdam, Excerpta Medica, 1968.
7. Burastero S.E., Casali P., Wilder A.L., Notkins A.L.: Monoreactive high affinity and polyreactive low affinity rheumatoid factors are produced by CD 5 + B cells from patients with rheumatoid arthritis. J. Exp. Med., 1988, 168, 1979.
8. Carson D.A.: Rheumatoid factor. Textbook of Rheumatology, ed. W.N. Kelly, E.D. Harris Jr., S. Ruddy, C.B. Sledge, W.B. Saunders, Philadelphia 1981, 677-690.
9. Clague R.B., Firth S.A., Holt P.J.L. et al.: Serum antibodies to type II collagen in rheumatoid arthritis; comparison of 6 immunological methods and clinical features. Ann. Rheum. Dis., 1983, 42, 537.
10. Cooke T.D., Hurd E.R., Jasin H.E. et al.: Identification of immunoglobulins and complement in rheumatoid articular collagenous tissues. Arthritis Rheum., 1975, 18, 541.
11. Cordonnier C., Meyer O., Palazzo E. et al.: Diagnostic value of anti-Ra-33 antibody, antikeratin antibody, antiperinuclear factor and antinuclear antibody in early RA comparison with rheumatoid factor. Br. J. Rheumatol., 1996, 35, 620.
12. Despres N., Boire G., Lopez-Longo F.J. et al.: The Sa system: a novel antigen-antibody system specific for rheumatoid arthritis. J. Rheumatol., 1994, 21, 1027.
13. Devauchelle Pensec V., Saraux A., Youinou P.: Antiperinuclear factor and antikeratin/antifilaggrin antibodies for differentiating early rheumatoid arthritis from polymyalgia rheumatica. Joint Bone Spine, 2001, 68, 306.
14. Elkon K.B., Gharavi A.E., Patel B.N. et al.: IgA and IgM rheumatoid factors in serum, saliva and other secretions. Relationship to immunoglobulin ratios in systemic sicca syndrom and rheumatoid arthritis. Clin. Exp. Immunol., 1983, 52, 161.
15. Epstein W.V., Engelman E.P.: The relation of rheumatoid factor content of serum to clinical neurovascular manifestations of rheumatoid arthritis. Arthritis. Rheum., 1959, 2, 250.
16. Ermel R., Kenny T., Roberts D.: Allotype dependent stimulation of T lymphocytes and rheumatoid factor production by IgG-3 in rheumatoid arthritis. Arthritis Rheum., 1990, 33, S 95.
17. Fong S., Vaughan J.H., Carson D.A.: Two different rheumatoid factor - producing cell populations distinguished by the mouse erythrocyte receptor and responsiveness to polyclonal B cell activators. J. Immunol., 1983, 130, 162.
18. Gioud - Paquet M., Auvinet M., Raffin T.: IgM rheumatoid factor (RF), IgA RF, IgE RF and IgG RF detected by ELISA in rheumatoid arthritis. Ann. Rheum. Dis., 1987, 46, 65.
19. Hassfeld W., Steiner G., Hartmuth K. et al.: Demonstration of a new antinuclear antibody (anti RA-33) that is highly specific for rheumatoid arthritis. Arthritis Rheum. 1989, 32, 1515.
20. Hassfeld W., Steiner G., Studnicka-Renke A. et al.: Autoimmune response to the spliceosome. Arthritis Rheum., 1995, 38, 777.
21. Hassfeld W., Steiner G., Graninger W. et al.: Antibody to the nuclear antigen Ra-33: a marker for early rheumatoid arthritis. Br. J. Rhematol., 1993, 32, 199.
22. Hayem G., Chazerain P., Combe B. et al.: Anti-Sa antibody is an accurate diagnostic and prognostic marker in adult rheumatoid arthritis. J. Rhematol., 1991, 26, 7.
23. Hendrich C., Kuipers J.G., Kolanus W. et al.: Activation of CD 16+ effector cells by rheumatoid factor complex. Role of natural killer cells in rheumatoid arthritis. Arthritis Rheum., 1991, 34, 423.
24. Hoet R.M., Van Venrooij W.J.: The antiperinuclear factor antikeratin antibodies in rheumatoid arthritis. In: Rheumatoid Arthritis, Smolen J., Kalden J., Maini R.N. (eds.) Springer-Verlag. Berlin 1992, 299-318.
25. Hoet R.M., Boerbooms A.M., Arends M. et al.: Antiperinuclear factor, a marker autoantibody for rheumatoid arthritis: colocalisation of the perinuclear factor and profilaggrin. Ann. Rheum. Dis., 1991, 50, 611.
26. Hoffman W.L., Goldberg M.S., Smiley J.D.: IgG-3 subclass production by rheumatoid synovial tissue cultures. J. Clin. Invest., 1982, 69, 136.
27. Jasin H.F.: Autoantibody specificities of immune complexes sequestered in articular cartilage of patients with rheumatoid arthritis and osteoarthritis. Arthritis Rheum., 1985, 28, 241.
28. Karsh J., Halbert S.P., Klima E., Steinberg A.D.: Quantitative determination of rheumatoid factor by an enzyme labeled immunoassay. J. Immunol. Methods, 1980, 32, 115.
29. Kroot E-J.J., De Jong B.A., Van Leeuwen M.A. et al.: The prognostic value of anti-cyclic citrullinated peptide antibody in patients with recent-onset rheumatoid arthritis. Arthritis Rheum., 2000, 43, 1831.
30. Małdyk E.: Anatomia patologiczna choroby reumatoidalnej. Choroby narza̧du ruchu. W: Reumatologia kliniczna, red. W. Brühl, PZWL, Warszawa 1969, 168-179.
31. Masi A.T., Maldonado-Cocco J.A., Kaplan S.B. et al.: Prospective study of the early course of rheumatoid arthritis in young adults: Comparison of patients with and without rheumatoid factor positivity at entry and identification of variables correlation with outcome. Semin. Arthritis Rheum., 1976, 5, 299.
32. Mc Kinley-Grant L.J., Idler W.W., Bernstein D.A. et al.: Characterization of cDNA clone encoding human filaggrin and localization of the gene to chromosome region 1q21. Proc. Natl. Acad. USA, 1989, 86, 4848.
33. Menard H.A., El-Amine M.: The calpain-calpastatin system in rheumatoid arthritis. Immunol. Today, 1996, 17, 545.
34. 14C-radioimmunoassay. Arthritis Rheum., 1978, 21, 243.
35. Meyer O., Tauxe F., Fabregas D.: Anti-Ra33 antinuclear antibody in rheumatoid arthritis and mixed connective tissue disease: comparison with antikeratin and antiperinuclear antybodies. Clin. Exp. Rhematol., 1993, 11, 473.
36. Mongan E.S., Cass R.M., Jacox R.F., Vaughan J.H.: A study of the relation of seronegative and seropositive rheumatoid arthritis to each other and to necrotizing vasculitis. Am. J. Med., 1969, 47, 23.
37. Natvig J.B., Munthe E.: Self-associating IgG rheumatoid factor represents a major response of plasma cells in rheumatoid inflammatory tissue. Ann. NY. Acad. Sci., 1975, 256, 88.
38. Nienhuis R.L.F., Mandema E.A.: A new serum factor in patients with rheumatoid arthritis, the antiperinuclearfactor. Ann. Rheum. Dis., 1964, 23, 302.
39. Nogueira L., Sebbeg M., Vincent C. et al.: Performance of two ELISAs for antifilaggrin autoantibodies, using either affinity purified or deiminated recombinant human filaggrin, in the diagnosis of rheumatoid arthritis. Ann. Rheum. Dis., 2001, 60, 882.
40. Palster B.: Rheumatoid disease and their management. Medical Tribune, Wisbaden, 1999.
41. Pope R.M., Teller D.C., Mannik M.: The molecular basis of self association of autoantibodies to IgG (rheumatoid factor) in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA, 1974, 71, 517.
42. Robbins D.L., Moore T.L., Carson D.A., Voughan J.H.: Relative reactivities of rheumatoid factors in serum and cells: evidence for selective deficiency in serum rheumatoid factor. Arthritis Rheum., 1978, 21, 820.
43. Robbins D.L., Skilling J., Benisek W.F., Wistar J.: Estimation of the relative avidity of 19S IgM rheumatoid factor secreted by rheumatoid synovial cells for human IgG subclasses. Arthritis Rheum., 1986, 29, 722.
44. Ropes M.W., Bennet G.A., Cobb S. et al: 1958 revision of diagnostic criteria of rheumatoid arthritis. Bull. Rheum. Dis., 1958, 9, 175.
45. Rose H.M., Ragan C., Pearce E., Lipman M. O.: Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc. Soc. Exp. Biol. Med., 1948, 68, 1.
46. Sabharwal U.K., Vaughan J.H., Fong S. et al.: Activation of classical pathway of complement by rheumatoid factors: assessment by radioimmunoassay for C4. Arthritis Rheum., 1982, 25, 161.
47. Shellekens G.A., de Jong B.A.W., van den Hoogen F.H.J. et al.: Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis-specific autoantibodies. J. Clin. Invest., 1998, 101, 273.
48. Schellekens G.A., Visser H., de Jong B.A.W. et al.: The diagnostic properties of rheumatoid arthritis antibodies recognizing a cyclic cytrullinated peptide. Arthritis Rheum., 2000, 43: 1555-63.
49. Sebbeg M., Simon M., Vincent C. et al.: The antiperinuclear factor and the so-called anti-keratin antibodies are the same rheumatoid arthritis-specific autoantibodies. J. Clin. Invest., 1995, 95, 2672.
50. Shmerling R.H., Thomas M.D., Delbanco M.D.: The rheumatoid factor: an analysis of clinical utility. Am. J. Med., 1991, 91, 528.
51. Simon M., Girbal E., Sebbag M. et al.: The cytokeratin filament-aggregating protein filaggrin is the target of so-called "antikeratin antibodies" specific for rheumatoid arthritis. J. Clin. Invest., 1993, 92, 1387.
52. Smolen J.S.: Antibodies in rheumatoid arthritis. Autoantibody Mannual. 1996, C1.1., 18.
53. Steffen C.: Consideration of the pathogenesis of rheumatoid arthritis as collagen autoimmunity. Z. Immunitatsforsch, 1970, 139, 219.
54. Steiner G., Hartmuth K., Skriner K. et al.: Purification and partial sequencing of the nuclear autoantigen RA33 shows that it is indistinguishable from the A2 protein of the heterogeneous nuclear ribonucleoprotein complex. J. Clin. Inves., 1992, 90, 1061.
55. Tarkowski A., Nilsson L.A.: Isotype specific measurement of rheumatoid factor with reference to clinical features of rheumatoid arthritis. J. Clin. Lab. Immunol., 1983, 12, 129.
56. Waaler E.: On the occurance of a factor in human serum activating the specific agglutination of sheep blood corpuscles. Acta. Pathol. Microbiol. Scand., 1940, 17, 172.
57. Williams R.C. Jr.: Rheumatoid factor: historical perspective, origins and possible role in diseases. J. Rheumatol., 1992, Suppl., 33, 19, 42.
58. Williams R. C. Jr.: Rheumatoid factors and other serum components associated with rheumatoid arthritis. Rheumatoid Arthritis as a systemic Diseases. W.B. Saunders, Philadelphia 1974, 162.
59. Winchester R.J., Agnello V., Kunkel H.G.: Gamma globulin complexes in synovial fluids of patients with rheumatoid arthritis: partial characterization and relationship to lowered complement levels. Clin. Exp. Immunol., 1970, 6, 689.
60. Young B., Mallya R., Leslie R. et al.: Antikeratin antibodies in rheumatoid arthritis. Br. Med. J., 1979, 2, 97.
61. Zqbek J., Brzezicki J., Biernacka E. i wsp.: Przeciwciala przeciw cytokeratynie jako marker wczesnego reumatoidalnego zapalenia stawów. Reumatologia, 2001, 39, 4, 303.